Symbols / UPC
UPC Chart
About
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 1.66M |
| Enterprise Value | -22.65M | Income | -3.67M | Sales | 17.86M |
| Book/sh | 99.64 | Cash/sh | 59.63 | Dividend Yield | — |
| Payout | 0.00% | Employees | 216 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.09 | P/B | 0.03 | P/C | — |
| EV/EBITDA | 9.44 | EV/Sales | -1.27 | Quick Ratio | 3.55 |
| Current Ratio | 4.07 | Debt/Eq | 16.49 | LT Debt/Eq | — |
| EPS (ttm) | -8.06 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -14.10% | Earnings | — | ROA | -2.66% |
| ROE | -7.23% | ROIC | — | Gross Margin | 35.28% |
| Oper. Margin | -6.77% | Profit Margin | -20.56% | Shs Outstand | 563.34K |
| Shs Float | 559.87K | Short Float | 2.09% | Short Ratio | 0.47 |
| Short Interest | — | 52W High | 11.00 | 52W Low | 2.51 |
| Beta | 1.52 | Avg Volume | 93.36K | Volume | 3.10K |
| Target Price | — | Recom | None | Prev Close | $2.98 |
| Price | $2.95 | Change | -1.01% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.99
Latest analyst target
3. DCF / Fair value
$-327.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.99
Low
—
High
—
Mean
—
News
RSS: Latest UPC news- Universe Pharmaceuticals INC Implements Dual-Class Share Structure on Nasdaq Effective February 13, 2026 - Quiver Quantitative Wed, 11 Feb 2026 21
- Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 31% - Sahm ue, 25 Nov 2025 08
- Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure - GlobeNewswire Wed, 11 Feb 2026 21
- Universe Pharmaceuticals Inc (UPC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade Wed, 08 Oct 2025 14
- Universe Pharmaceuticals Sets February 13 Effective Date for Dual-Class Share Structure - TipRanks Wed, 11 Feb 2026 08
- UPC Stock Surges as Strategic Moves Drive Market Confidence - timothysykes.com Sat, 27 Dec 2025 08
- UPC denies Abbott second injunction against Sinocare - JUVE Patent hu, 23 Oct 2025 07
- The UPC: taking stock after two transformative years - Managing Intellectual Property hu, 10 Jul 2025 07
- Universe Pharmaceuticals INC Announces Share Consolidation Effective March 24, 2025 - Nasdaq hu, 20 Mar 2025 07
- FDA updates risk classification for voluntary shredded cheese recall - Good Morning America Wed, 03 Dec 2025 08
- SoFi Stock Falls Ahead of Q4 Earnings -- What To Expect From Upc - GuruFocus ue, 20 Jan 2026 08
- Is Universe Stock Soaring? Can It Sustain? - StocksToTrade Wed, 08 Oct 2025 07
- Top 10 patent cases of the year 2025 - JUVE Patent Mon, 29 Dec 2025 08
- Universe Pharmaceuticals Stock Movement: A Detailed Insight - timothysykes.com Wed, 08 Oct 2025 07
- UPC Stock Surges Amid Strategic Announcements - StocksToTrade Fri, 26 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.25 | 0.25 | 0.25 |
| NormalizedEBITDA | -2.44M | -7.36M | -3.66M | -6.40M |
| TotalUnusualItems | -481.11K | 0.00 | 0.00 | -470.48K |
| TotalUnusualItemsExcludingGoodwill | -481.11K | 0.00 | 0.00 | -470.48K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -3.67M | -8.73M | -6.58M | -7.91M |
| ReconciledDepreciation | 517.43K | 485.73K | 508.79K | 533.95K |
| ReconciledCostOfRevenue | 11.29M | 16.68M | 21.68M | 17.90M |
| EBITDA | -2.92M | -7.36M | -3.66M | -6.40M |
| EBIT | -3.44M | -7.84M | -4.17M | -6.93M |
| NetInterestIncome | -232.04K | -278.17K | -156.79K | -162.40K |
| InterestExpense | 232.04K | 278.17K | 156.79K | 162.40K |
| NormalizedIncome | -3.19M | -8.73M | -6.58M | -7.91M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -3.67M | -8.73M | -6.58M | -7.91M |
| TotalExpenses | 20.77M | 31.04M | 36.27M | 47.16M |
| TotalOperatingIncomeAsReported | -2.92M | -8.02M | -3.97M | -7.02M |
| DilutedAverageShares | 13.92K | 6.04K | 5.92K | 4.49K |
| BasicAverageShares | 13.92K | 6.04K | 5.92K | 4.49K |
| DilutedEPS | -626.96 | -1.09K | -1.34K | 2.52K |
| BasicEPS | -626.96 | -1.09K | -1.34K | 2.52K |
| DilutedNIAvailtoComStockholders | -3.67M | -8.73M | -6.58M | -7.91M |
| NetIncomeCommonStockholders | -3.67M | -8.73M | -6.58M | -7.91M |
| NetIncome | -3.67M | -8.73M | -6.58M | -7.91M |
| NetIncomeIncludingNoncontrollingInterests | -3.67M | -8.73M | -6.58M | -7.91M |
| NetIncomeContinuousOperations | -3.67M | -8.73M | -6.58M | -7.91M |
| TaxProvision | 0.00 | 606.70K | 2.25M | 815.32K |
| PretaxIncome | -3.67M | -8.12M | -4.33M | -7.09M |
| OtherIncomeExpense | -524.10K | 177.42K | -204.54K | 87.53K |
| OtherNonOperatingIncomeExpenses | -108.04K | 145.48K | -235.61K | 48.94K |
| SpecialIncomeCharges | -481.11K | 0.00 | 0.00 | -419.35K |
| WriteOff | -439.33K | 419.35K | -230.18K | |
| ImpairmentOfCapitalAssets | 481.11K | 0.00 | 0.00 | |
| EarningsFromEquityInterest | 65.06K | 31.94K | 31.07K | 38.59K |
| GainOnSaleOfSecurity | 38.53K | -470.48K | 239.55K | |
| NetNonOperatingInterestIncomeExpense | -232.04K | -278.17K | -156.79K | -162.40K |
| InterestExpenseNonOperating | 232.04K | 278.17K | 156.79K | 162.40K |
| OperatingIncome | -2.92M | -8.02M | -3.97M | -7.02M |
| OperatingExpense | 9.22M | 14.09M | 14.28M | 28.91M |
| OtherOperatingExpenses | 17.91K | 28.84K | 47.15K | 39.55K |
| OtherTaxes | 392.18K | 246.24K | 179.19K | 205.58K |
| ProvisionForDoubtfulAccounts | -113.45K | 131.58K | 0.00 | 419.35K |
| DepreciationAmortizationDepletionIncomeStatement | 246.34K | 209.60K | 195.45K | 185.17K |
| DepreciationAndAmortizationInIncomeStatement | 246.34K | 209.60K | 195.45K | 185.17K |
| ResearchAndDevelopment | 671.76K | 3.60M | 4.86M | 7.64M |
| SellingGeneralAndAdministration | 8.00M | 9.88M | 9.00M | 20.84M |
| SellingAndMarketingExpense | 3.80M | 6.69M | 6.01M | 18.30M |
| GeneralAndAdministrativeExpense | 4.21M | 3.19M | 3.00M | 2.53M |
| OtherGandA | 2.56M | 1.54M | 1.49M | 1.11M |
| SalariesAndWages | 1.65M | 1.65M | 1.51M | 1.42M |
| GrossProfit | 6.30M | 6.07M | 10.32M | 21.89M |
| CostOfRevenue | 11.56M | 16.95M | 21.99M | 18.25M |
| TotalRevenue | 17.86M | 23.02M | 32.31M | 40.14M |
| OperatingRevenue | 17.86M | 23.02M | 32.31M | 40.14M |
| Line Item | 2023-09-30 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 563.34K | 39.41K | 6.08K | 6.04K |
| ShareIssued | 563.34K | 39.41K | 6.08K | 6.04K |
| NetDebt | 197.21K | |||
| TotalDebt | 9.26M | 7.99M | 5.48M | 3.94M |
| TangibleBookValue | 55.83M | 45.24M | 27.82M | 46.28M |
| InvestedCapital | 65.39M | 53.50M | 33.45M | 50.38M |
| WorkingCapital | 40.43M | 31.32M | 11.52M | 28.41M |
| NetTangibleAssets | 55.83M | 45.24M | 27.82M | 46.28M |
| CommonStockEquity | 56.13M | 45.50M | 27.97M | 46.44M |
| TotalCapitalization | 56.13M | 47.64M | 27.97M | 46.44M |
| TotalEquityGrossMinorityInterest | 56.13M | 45.50M | 27.97M | 46.44M |
| StockholdersEquity | 56.13M | 45.50M | 27.97M | 46.44M |
| GainsLossesNotAffectingRetainedEarnings | 626.01K | 1.33M | 67.30K | 772.83K |
| OtherEquityAdjustments | 626.01K | 1.33M | 67.30K | 772.83K |
| RetainedEarnings | -13.84M | -10.17M | -1.44M | 16.32M |
| AdditionalPaidInCapital | 63.01M | 53.86M | 29.28M | 29.28M |
| CapitalStock | 6.34M | 482.40K | 67.97K | 67.97K |
| CommonStock | 6.34M | 482.40K | 67.97K | 67.97K |
| TotalLiabilitiesNetMinorityInterest | 13.17M | 22.45M | 13.75M | 13.10M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 2.14M | 0.00 | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 2.14M | |||
| LongTermDebt | 2.14M | |||
| CurrentLiabilities | 13.17M | 20.31M | 13.75M | 13.10M |
| CurrentDeferredLiabilities | 40.71K | 0.00 | ||
| CurrentDeferredRevenue | 40.71K | 0.00 | ||
| CurrentDebtAndCapitalLeaseObligation | 9.26M | 5.86M | 5.48M | 3.94M |
| CurrentDebt | 9.26M | 5.86M | 5.48M | 3.94M |
| OtherCurrentBorrowings | 2.11M | 5.86M | 5.48M | |
| LineOfCredit | 7.15M | 5.86M | 5.48M | 3.94M |
| PayablesAndAccruedExpenses | 3.88M | 14.46M | 8.27M | 9.16M |
| CurrentAccruedExpenses | 262.62K | 352.85K | 2.71M | 2.54M |
| Payables | 3.61M | 14.10M | 5.56M | 6.62M |
| OtherPayable | 856.57K | 1.27M | ||
| DuetoRelatedPartiesCurrent | 446.55K | 6.90M | 540.10K | 3.38M |
| TotalTaxPayable | 640.78K | 1.02M | 434.76K | 167.35K |
| IncomeTaxPayable | 0.00 | 669.78K | ||
| AccountsPayable | 1.67M | 4.91M | 4.59M | 3.08M |
| TotalAssets | 69.30M | 67.95M | 41.72M | 59.54M |
| TotalNonCurrentAssets | 15.70M | 16.32M | 16.45M | 18.03M |
| NonCurrentPrepaidAssets | 0.00 | 35.86K | 2.25M | 2.48M |
| NonCurrentDeferredAssets | 0.00 | 599.08K | 1.35M | 870.00K |
| NonCurrentDeferredTaxesAssets | 0.00 | 599.08K | 1.35M | 870.00K |
| InvestmentsAndAdvances | 702.35K | 712.49K | 685.31K | 702.89K |
| InvestmentinFinancialAssets | 702.35K | 712.49K | 685.31K | 702.89K |
| AvailableForSaleSecurities | 702.35K | 712.49K | 685.31K | 702.89K |
| GoodwillAndOtherIntangibleAssets | 296.79K | 262.88K | 148.58K | 157.45K |
| OtherIntangibleAssets | 296.79K | 262.88K | 148.58K | 157.45K |
| NetPPE | 14.70M | 15.34M | 14.99M | 15.83M |
| AccumulatedDepreciation | -6.90M | -6.66M | -6.05M | -5.71M |
| GrossPPE | 21.60M | 22.01M | 21.04M | 21.54M |
| ConstructionInProgress | 11.15M | 11.81M | 11.29M | 11.58M |
| MachineryFurnitureEquipment | 2.87M | 2.60M | 2.45M | 2.47M |
| BuildingsAndImprovements | 7.58M | 7.59M | 7.30M | 7.49M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 53.60M | 51.64M | 25.27M | 41.51M |
| OtherCurrentAssets | 39.94K | 852.42K | 37.18K | 1.72M |
| CurrentDeferredAssets | 0.00 | |||
| PrepaidAssets | 4.59M | 1.67M | 4.09M | 3.53M |
| Inventory | 2.19M | 1.74M | 3.34M | 2.21M |
| InventoriesAdjustmentsAllowances | -122.74K | -124.51K | -69.75K | -120.29K |
| OtherInventories | -1.00 | |||
| FinishedGoods | 1.61M | 1.14M | 2.78M | 1.34M |
| RawMaterials | 707.43K | 720.04K | 635.39K | 989.04K |
| Receivables | 13.19M | 17.88M | 12.52M | 15.18M |
| OtherReceivables | 177.90K | 4.97M | 1.44M | |
| DuefromRelatedPartiesCurrent | 0.00 | 61.68K | 0.00 | 236.98K |
| AccountsReceivable | 13.01M | 12.91M | 11.01M | 15.18M |
| AllowanceForDoubtfulAccountsReceivable | -18.21K | -135.08K | 0.00 | -791.83K |
| GrossAccountsReceivable | 13.03M | 13.04M | 11.01M | 15.98M |
| CashCashEquivalentsAndShortTermInvestments | 33.59M | 29.50M | 5.29M | 18.86M |
| OtherShortTermInvestments | 13.22M | 13.15M | 13.73M | |
| CashAndCashEquivalents | 33.59M | 29.50M | 5.29M | 5.71M |
| CashFinancial | 33.59M | 29.50M | 5.29M | 5.71M |
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| FreeCashFlow | -5.40M | -9.87M | 1.07M | -1.40M |
| RepaymentOfDebt | -15.54M | -8.36M | -10.60M | -4.27M |
| IssuanceOfDebt | 10.27M | 17.32M | 9.21M | 7.59M |
| IssuanceOfCapitalStock | 15.00M | 25.00M | 0.00 | 0.00 |
| CapitalExpenditure | -347.19K | -363.09K | -44.17K | -93.70K |
| InterestPaidSupplementalData | 289.38K | 304.52K | 190.18K | 199.85K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 863.80K | 2.75M |
| EndCashPosition | 33.59M | 29.50M | 5.29M | 5.71M |
| BeginningCashPosition | 29.50M | 5.29M | 5.71M | 8.08M |
| EffectOfExchangeRateChanges | -237.67K | 126.09K | -108.17K | -474.73K |
| ChangesInCash | 4.33M | 24.09M | -318.04K | -1.89M |
| FinancingCashFlow | 9.73M | 33.95M | -1.39M | 3.32M |
| CashFlowFromContinuingFinancingActivities | 9.73M | 33.95M | -1.39M | 3.32M |
| NetOtherFinancingCharges | -3.09M | 3.32M | -3.70M | |
| CashDividendsPaid | 0.00 | 0.00 | ||
| CommonStockDividendPaid | 0.00 | 0.00 | ||
| NetCommonStockIssuance | 15.00M | 25.00M | 0.00 | 0.00 |
| CommonStockIssuance | 15.00M | 25.00M | 0.00 | 0.00 |
| NetIssuancePaymentsOfDebt | -5.27M | 8.95M | -1.39M | 3.32M |
| NetShortTermDebtIssuance | 1.70M | 0.00 | 1.54M | |
| ShortTermDebtPayments | -3.97M | -4.27M | -2.76M | |
| ShortTermDebtIssuance | 5.67M | 4.27M | 4.30M | |
| NetLongTermDebtIssuance | -5.27M | 8.95M | -1.39M | 3.32M |
| LongTermDebtPayments | -15.54M | -8.36M | -10.60M | -4.27M |
| LongTermDebtIssuance | 10.27M | 17.32M | 9.21M | 7.59M |
| InvestingCashFlow | -341.81K | -361.29K | -44.17K | -3.91M |
| CashFlowFromContinuingInvestingActivities | -341.81K | -361.29K | -44.17K | -3.91M |
| NetInvestmentPurchaseAndSale | 0.00 | 0.00 | -13.53M | |
| SaleOfInvestment | 0.00 | 0.00 | 1.80M | |
| PurchaseOfInvestment | 0.00 | 0.00 | -15.33M | |
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | -3.81M | 0.00 |
| PurchaseOfBusiness | 0.00 | 0.00 | -3.81M | 0.00 |
| NetIntangiblesPurchaseAndSale | -80.42K | -117.29K | 0.00 | 0.00 |
| PurchaseOfIntangibles | -80.42K | -117.29K | 0.00 | 0.00 |
| NetPPEPurchaseAndSale | -261.39K | -243.99K | -44.17K | -93.18K |
| SaleOfPPE | 5.38K | 1.80K | 0.00 | 523.00 |
| PurchaseOfPPE | -266.77K | -245.80K | -44.17K | -93.70K |
| OperatingCashFlow | -5.05M | -9.51M | 1.12M | -1.30M |
| CashFlowFromContinuingOperatingActivities | -5.05M | -9.51M | 1.12M | -1.30M |
| ChangeInWorkingCapital | -2.27M | -2.06M | 5.67M | 6.60M |
| ChangeInOtherWorkingCapital | 40.18K | -947.96K | ||
| ChangeInPayablesAndAccruedExpense | -4.25M | -469.03K | 2.17M | -505.34K |
| ChangeInAccruedExpense | -85.44K | -31.47K | 170.05K | 2.32M |
| ChangeInPayable | -4.16M | -437.57K | 2.00M | -2.82M |
| ChangeInAccountPayable | -3.13M | 143.75K | 1.64M | -1.92M |
| ChangeInTaxPayable | -324.53K | 554.42K | 280.94K | -904.13K |
| ChangeInIncomeTaxPayable | -324.53K | 554.42K | 280.94K | -904.13K |
| ChangeInPrepaidAssets | -715.73K | -1.53M | 526.13K | 9.64M |
| ChangeInInventory | -474.63K | 1.64M | -1.18M | 16.59K |
| ChangeInReceivables | 3.13M | -1.71M | 5.11M | -2.56M |
| ChangesInAccountReceivables | -168.96K | -1.55M | 4.72M | -1.53M |
| ProvisionandWriteOffofAssets | -113.45K | 182.23K | -49.17K | 15.77K |
| AssetImpairmentCharge | 481.11K | 0.00 | 0.00 | |
| DeferredTax | 0.00 | 606.70K | 1.57M | -542.38K |
| DeferredIncomeTax | 0.00 | 606.70K | 1.57M | -542.38K |
| DepreciationAmortizationDepletion | 517.43K | 485.73K | 508.79K | 533.95K |
| DepreciationAndAmortization | 517.43K | 485.73K | 508.79K | 533.95K |
| OperatingGainsLosses | 2.95K | 3.96K | 114.00 | 983.00 |
| GainLossOnInvestmentSecurities | -38.53K | 470.48K | -239.55K | |
| GainLossOnSaleOfPPE | 2.95K | 3.96K | 114.00 | 983.00 |
| NetIncomeFromContinuingOperations | -3.67M | -8.73M | -6.58M | -7.91M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for UPC
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|